Monsanto adds another CRISPR platform to genetic toolbox

 Monsanto Company has forged an agreement with ToolGen, Inc., a biotechnology company specializing in genome editing, to use ToolGen’s CRISPR technology platform to develop agricultural products. The companies announced Aug. 16 that they have reached a global licensing agreement for Monsanto to access ToolGen’s suite of CRISPR intellectual property for use in plants.